Artemis Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -434%. Total operating expenses were $1,616,000.

Profit Margin

Artemis Therapeutics Inc. (OTC:ATMS): Profit margin
2013 1.28M -298K -23.14%
2014 244K 362K 148.36%
2015 0 -139K
2016 0 -264K
2017 0 -1.14M
2018 259K -513K -198.07%
2019 0 -121K
2020 0 -121K
2021 0 -180K
2022 311K -1.35M -434.41%

ATMS Income Statement (2013 โ€“ 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
311K000259K000244K1.28M
Cost of revenue
54K000000040K564K
Gross profit
257K000259K000204K724K
Operating exp.
Research and development
0000246K309K89K048K303K
Selling and marketing
664K000000043K205K
Total operating expenses
1.61M154K167K168K772K1.03M255K164K554K1.07M
Operating income
-1.35M-154K-167K-168K-772K-1.03M-255K-164K-350K-351K
Other income (expenses), net
4K-13K-7K-6K259K-104K-9K25K712K53K
Income before tax
-1.35M-167K-174K-174K-513K-1.14M-264K-139K362K-298K
Income tax expense
-4K13K-53K-53K0000712K53K
Net income
-1.35M-180K-121K-121K-513K-1.14M-264K-139K362K-298K
Earnings per share
Basic EPS
0-0.00-0.02-0.02-0.09-0.23-0.05-0.160.42-0.35
Diluted EPS
0-0.00-0.02-0.02-0.09-0.23-0.05-0.160.42-0.35
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source